Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi Research Article, Int J Cardiovasc Res Vol: 3 Issue: 4
Usefulness of BNP in Monitoring Response to Treatment in Patients with Pulmonary Arterial Hypertension (PAH)
| Alhaj EK*, Alhaj EKN, Rahman I, Thirunahari N, Solanki P, Voudouris A, Hamirani K, Ghesani N, Gerula C, Oriscello RG, Klapholz M and Berkowitz RL |
| Department of Medicine, Division of Cardiology, Rutgers University, New Jersey, USA |
| Corresponding author : Eyad Alhaj Department of Medicine, Division of Cardiology, Rutgers New Jersey Medical School, Rutgers University, 185 South Orange Avenue, Newark, New Jersey 07103, USA Tel: 513-2273354 E-mail: eyadalhaj@yahoo.com |
| Received: May 14, 2014 Accepted: August 13, 2014 Published: August 20, 2014 |
| Citation: Alhaj EK, Alhaj EKN, Rahman I, Thirunahari N, Solanki P, et al. (2014) Usefulness of BNP in Monitoring Response to Treatment in Patients with Pulmonary Arterial Hypertension (PAH). Int J Cardiovasc Res 3:5. doi:10.4172/2324-8602.1000183 |
Abstract
Usefulness of BNP in Monitoring Response to Treatment in Patients with Pulmonary Arterial Hypertension (PAH)
This is a retrospective study that sought to analyze the usefulness of monitoring Brain Natriuretic Peptide (BNP) levels, over time, to determine the response to treatment in patients with Pulmonary Arterial Hypertension (PAH); the study also sought to determine if any of the echocardiographic and hemodynamic variables, measured at baseline, can predict a favorable response.
